CORRECTION article

Front. Genet., 22 September 2021

Sec. RNA

Volume 12 - 2021 | https://doi.org/10.3389/fgene.2021.715061

Corrigendum: Histone Deacetylase 3 Aggravates Type 1 Diabetes Mellitus by Inhibiting Lymphocyte Apoptosis Through the microRNA-296-5p/Bcl-xl Axis

  • Department of Pediatrics, The Second Hospital of Jilin University, Changchun, China

In the original article, there was a mistake in Table 1 as published. We misplaced the forward primer and reverse primer when typesetting, which has been adjusted. The corrected Table 1 appears below.

Table 1

PrimerPrimer sequences (5′-3′)
GapdhF: TGATGGGTGTGAACCACGAGR: TCAGTGTAGCCCAAGATGCC
U6F: CTCGCTTCGGCAGCACAR: AACGTTCACGAATTTGCGT
Bcl-xlF: CTGAATCGGAGATGGAGACCR: TGGGATGTCAGGTCACTGAA
Hdac3F: CACCCTATGAAGCCCCATCGR: GAGACCGTAATGCAGGACCAG
miR-296-5pF: CGACGAGGGCCCCCCCTR: GTATCCAGTGCAGG GTCCGA

Primer sequences used in RT-qPCR analysis.

RT-qPCR, reverse transcription-quantitative polymerase chain reaction; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; Bcl-xl, B-cell leukemia-XL; Hdac3, histone deacetylase 3; miR-296-5p, microRNA-296-5p; F, forward; R, reverse.

Additionally, there was also a mistake in the text of the published article. We are sorry that the previous method description was not clear enough. Now we have modified the related method description: “For reverse transcription (RT) of mRNA, 1 μg of RNA was synthesized into cDNA at 42°C for 50 min by using the TaqMan RT reagent (Roche, Canton of Basel, Switzerland). For the RT of miRNA, specific stem-loop primers were used to synthesize cDNA.”

A correction has been made to Methods, RNA Isolation and Quantitation, Paragraph 1:

Total RNA from tissues or cells was extracted using the miRNeasy Mini kit (QIAGEN, GmbH, Hilden, Germany) and subsequently quantified using NanoDrop ND-1000 Spectrophotometer (NanoDrop Products, Wilmington, DE, USA), whereas RNA integrity was evaluated by microfluidic electrophoresis. For reverse transcription (RT) of mRNA, 1 μg of RNA was synthesized into cDNA at 42°C for 50 min by using the TaqMan RT reagent (Roche, Canton of Basel, Switzerland). For the RT of miRNA, specific stem-loop primers were used to synthesize cDNA.

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

histone deacetylase 3, microRNA-296-5p, B-cell leukemia-XL, type 1 diabetes mellitus, peripheral blood mononuclear cells, apoptosis

Citation

Hu Q, Che G, Yang Y, Xie H and Tian J (2021) Corrigendum: Histone Deacetylase 3 Aggravates Type 1 Diabetes Mellitus by Inhibiting Lymphocyte Apoptosis Through the microRNA-296-5p/Bcl-xl Axis. Front. Genet. 12:715061. doi: 10.3389/fgene.2021.715061

Received

26 May 2021

Accepted

24 August 2021

Published

22 September 2021

Volume

12 - 2021

Edited and reviewed by

Peter G. Zaphiropoulos, Karolinska Institutet (KI), Sweden

Updates

Copyright

*Correspondence: Jing Tian

This article was submitted to RNA, a section of the journal Frontiers in Genetics

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics